SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001390478-17-000034
Filing Date
2017-05-10
Accepted
2017-05-10 16:33:18
Documents
3
Period of Report
2017-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gale-201705108xk.htm 8-K 42184
2 EXHIBIT 99.1 gale-20170510ex991.htm EX-99.1 107796
3 prgraphic05072015pa16.jpg GRAPHIC 102112
  Complete submission text file 0001390478-17-000034.txt   292024
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 17830837
SIC: 2834 Pharmaceutical Preparations